Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
The effect of human serum on Escherichia coli was studied with serum-sensitive and serum-resistant strains. The bactericidal effect of human serum on serum-sensitive strains of E. coli depended on the activation of the classical complement pathway. The role of activation of the alternative pathway was less important. After incubation in sub-bactericidal concentrations of serum these strains were also easily phagocytosed by polymorphonuclear leukocytes (PMNL). Strains of E. coli of certain O-types required not only an intact classical pathway but also the presence of specific antibodies for effective killing by serum and effective phagocytosis by PMNL, despite rapid activation of complement and rapid deposition of C3 on the bacterial surface in the absence of antibody. Capsulate strains O1K1 and O78K80 resisted the bactericidal effect of serum even in the presence of specific antibodies; phagocytosis by PMNL only occurred after opsonisation with specific antibodies.
D000907:Antibodies, Bacterial / Q000276:immunology; D001433:Bacteriolysis; D001770:Blood Bactericidal Activity; D003167:Complement Activation; D003179:Complement C3b / Q000378:metabolism; D003171:Complement Pathway, Classical; D004926:Escherichia coli / Q000276:immunology*; D006801:Humans; D009504:Neutrophils / Q000276:immunology; D009895:Opsonin Proteins; D010587:Phagocytosis
D000907:Antibodies, Bacterial; D009895:Opsonin Proteins; D003179:Complement C3b